Anna Greka
Vermogen: - $ op 30-06-2026
Vermogen: - $ op 30-06-2026
Anna Greka is the founder of Goldfinch Bio, Inc., founded in 2016.
Current jobs include Director at Ovid Therapeutics, Inc. starting in 2026 and Professor at Harvard Medical School since 2012.
Education history includes a doctorate from Harvard Medical School and an undergraduate degree from Harvard University.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 15-06-2026 | 0 ( -.--% ) | - $ | 30-06-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| OVID THERAPEUTICS INC. | Directeur/Bestuurslid | 15-06-2026 |
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
| Bedrijven | Functie | Einde |
|---|---|---|
Goldfinch Bio, Inc.
Goldfinch Bio, Inc. Pharmaceuticals: MajorHealth Technology Develop medicines and therapies for patients with kidney disease | Oprichter | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 4 |
|---|---|
Ovid Therapeutics, Inc.
Ovid Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Provides medicines to children and adults with neurological disorders | Health Technology |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Goldfinch Bio, Inc.
Goldfinch Bio, Inc. Pharmaceuticals: MajorHealth Technology Develop medicines and therapies for patients with kidney disease | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau